-
PhD Studentship - Extending the Chemical Space of mAb Based Cancer Treatment with DNA Nanostructures
the Institute for Life Sciences (50%) and the Medical Research Council (50%). Due to funding restrictions this position is only open to UK applicants. Administrative contact and how to apply: Please complete
-
a joint venture between Medical Research Council, AstraZeneca and the University of Cambridge, this new laboratory aligns with the MTI's approach of breaking the mould in terms of how academia and
-
a joint venture between Medical Research Council, AstraZeneca and the University of Cambridge, this new laboratory aligns with the MTI's approach of breaking the mould in terms of how academia and
-
the ultimate aim of using this knowledge to tackle specific problems in human health and disease. We aim to tackle difficult, long-term problems, which often require investment over many years. There are four
-
understanding biological processes at the molecular level, with the ultimate aim of using this knowledge to tackle specific problems in human health and disease. We aim to tackle difficult, long-term problems